Vascular-like classical Ehlers-Danlos syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:230845
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Vascular-like classical Ehlers-Danlos syndrome (vascular-like cEDS) is an extremely rare subtype of classical Ehlers-Danlos syndrome that presents with features overlapping both classical and vascular forms of EDS. It is caused by specific mutations in the COL1A1 gene, which encodes the pro-alpha1 chain of type I collagen, a major structural protein found throughout the body. This condition is distinguished from typical classical EDS by the presence of vascular and organ complications — such as arterial rupture, organ rupture, or easy bruising with significant bleeding — that are more commonly associated with vascular EDS (caused by COL3A1 mutations), in addition to the hallmark features of classical EDS including marked skin hyperextensibility, atrophic scarring, and generalized joint hypermobility. The condition affects multiple body systems, including the skin, musculoskeletal system, and cardiovascular system. Patients may experience fragile skin that tears or bruises easily, poor wound healing with characteristic wide atrophic (cigarette-paper) scars, and joint hypermobility that can lead to recurrent dislocations and chronic pain. The vascular complications, which may include spontaneous arterial dissection or rupture, distinguish this subtype and can be life-threatening. Gastrointestinal fragility and organ rupture have also been reported. There is currently no cure for vascular-like classical EDS. Management is supportive and multidisciplinary, focusing on surveillance for vascular complications, skin and wound care, joint protection, physical therapy, and avoidance of activities or procedures that may increase the risk of vascular or tissue injury. Patients benefit from regular cardiovascular monitoring, and surgical interventions should be approached with caution due to tissue fragility. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Vascular-like classical Ehlers-Danlos syndrome.

View clinical trials →

No actively recruiting trials found for Vascular-like classical Ehlers-Danlos syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Vascular-like classical Ehlers-Danlos syndrome community →

No specialists are currently listed for Vascular-like classical Ehlers-Danlos syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Vascular-like classical Ehlers-Danlos syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Vascular-like classical Ehlers-Danlos syndromeForum →

No community posts yet. Be the first to share your experience with Vascular-like classical Ehlers-Danlos syndrome.

Start the conversation →

Latest news about Vascular-like classical Ehlers-Danlos syndrome

No recent news articles for Vascular-like classical Ehlers-Danlos syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Vascular-like classical Ehlers-Danlos syndrome

What is Vascular-like classical Ehlers-Danlos syndrome?

Vascular-like classical Ehlers-Danlos syndrome (vascular-like cEDS) is an extremely rare subtype of classical Ehlers-Danlos syndrome that presents with features overlapping both classical and vascular forms of EDS. It is caused by specific mutations in the COL1A1 gene, which encodes the pro-alpha1 chain of type I collagen, a major structural protein found throughout the body. This condition is distinguished from typical classical EDS by the presence of vascular and organ complications — such as arterial rupture, organ rupture, or easy bruising with significant bleeding — that are more commonly

How is Vascular-like classical Ehlers-Danlos syndrome inherited?

Vascular-like classical Ehlers-Danlos syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.